Mojtaba Akhtari, M.D.
UNMC Hematology and Oncology Division
987680 Nebraska Medical Center
Omaha, NE 68198-7680
Main practice location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987835 Nebraska Medical Center
Omaha, NE 68198-7835
Fellowship in Hematology and Medical Oncology: Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Residency in Internal Medicine: Saint Francis Hospital of Evanston (Major affiliation with University of Illinois in Chicago), Evanston, Illinois, USA.
Clinical and Laboratory Hematology: Department of Haematological Medicine, King’s College Hospital, London, and Farnborough Hospital, Kent, UK.
Internal Medicine: Bromley Hospitals, Bromley, Kent, and Westmoreland General Hospital, Cumbria, UK.
Tehran University of Medical Sciences, Tehran, Iran, M.D.
Assistant Professor of Medicine
The University of Nebraska Medical Center
Acute and chronic leukemias as well as myelodysplastic syndromes, myeloproliferative disorders, familial leukemias, immune cytopenia, and bone marrow transplantation.
Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in United Kingdom and United States of America. Dr. Akhtari is board certified in Internal Medicine, Hematology and Medical Oncology. His experience is fairly wide ranging having worked in academic teaching medical centers and community hospitals with high clinical workloads and a heavy reliance on clinical skills. He is also a member of adult bone marrow transplantation team. He has authored several book chapters and many articles in peer-reviewed journals. He received Humanism in Medicine Award at St. Francis Hospital of Evanston. He is an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).
O'Brien S, Radiich JP, Abboud CN, Akhtari M, Altman J, Berman E, Deangelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H. Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2013; 11: 1327-1340.
Aryal MR, Bhatt VR, Tandra P, Krishnamurthy J, Yuan J, Greiner TC, Akhtari M. Autoimmune Neutropenia in Multiple Myeloma and the Role of Clonal T-Cell Expansion: Evidence of Cross-Talk Between B-Cell and T-Cell Lineages? Clin Lymphoma Myeloma Leuk. 2013 Oct 29 [Epub ahead of print]
Minali NR, Bhatt VR, Kedia S, Krishnamurthy J, Wake LM, Akhtari M. Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis. J Oncol Pharm Pract. 2013 Sep 24. [Epub ahead of print]
Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, Chen PX, Armitage JO. Therapy-related myeloid neoplasms after autologous hematologic stem cell transplantation in lymphoma patients. Cancer Biol Ther. 2013 Sep 11; 14(12). [Epub ahead of print]
Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Management of Immune Cytopenias in patients with Systemic Lupus Erythematosus. Autoimmun Rev. 2013; 12: 784-791.
Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Mobilization of hematopoietic progenitors from normal donors using the combination of GM-CSF and G-CSF results in fewer pDC in graft and enhanced donor T-cell engraftment with Th1-polarization: results from a randomized clinical trial. Biol Blood Marrow Transplant, 2013; 19: 460-467.
Neeman K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012; 14: E161-E165.
Tang P, Perry AM, Akhtari M. A case of type B lactic acidosis in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2013;13:80-82.
Algarni AA, Akhtari M, Fu K. Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature. Case Report Hematol. 2012; 2012: 207537.
Newman K, Manesss-Harris L, El-Hemaidi I, Akhtari M. Revisiting use of growth factors in myelodysplastic syndromes. Asian Pac J Cancer Prev. 2012; 13: 1081-91.
Prodduturi P, Patricia Aoun P, Weisenburger DD, Perry AM, Akhtari M. Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report. J Oncol Pharm Pract. 2012 Mar 7. [Epub ahead of print]
- Breast Cancer
Stem Cell Transplantation
- Thoracic Oncology
- Urologic Oncology
- Partners & Facilities